News Cross Country Healthcare, Inc.

Equities

CCRN

US2274831047

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
16.44 ^USD	+2.62%		-6.59%	-27.39%

May. 06	Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating	MT
May. 01	(CCRN) CROSS COUNTRY HEALTHCARE Sees Q2 EPS Range $0.10 - $0.20	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating	May. 06	MT
Cross Country Healthcare to Attend Benchmark’s Healthcare House Call Investor Conference	May. 03	BU
(CCRN) CROSS COUNTRY HEALTHCARE Sees Q2 EPS Range $0.10 - $0.20	May. 01	MT
Earnings Flash (CCRN) CROSS COUNTRY HEALTHCARE Reports Q1 Revenue $379.2M, vs. Street Est of $374.4M	May. 01	MT
Earnings Flash (CCRN) CROSS COUNTRY HEALTHCARE Posts Q1 EPS $0.19, vs. Street Est of $0.17	May. 01	MT
Cross Country Healthcare Seeks M&A	May. 01	CI
Transcript : Cross Country Healthcare, Inc., Q1 2024 Earnings Call, May 01, 2024	May. 01
Cross Country: Q1 Earnings Snapshot	May. 01	AQ
Cross Country Healthcare Announces First Quarter 2024 Financial Results	May. 01	BU
Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2024	May. 01	CI
Cross Country Healthcare, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01	CI
Country Launches Future of Nursing Study Unveiling the Balance of AI Integration and Preserving Humanity in Healthcare	Apr. 25	BU
Cross Country Healthcare, Inc. Releases Latest Research Findings in the Fourth Annual Installment of the Future of Nursing Survey	Apr. 25	CI
Cross Country EVP, Chief Administrative Officer and General Counsel Named to Global Top 50 Corporate Counsel List	Apr. 24	BU
Cross Country Healthcare to Hold First Quarter 2024 Earnings Conference Call on Wednesday, May 1, 2024	Apr. 10	BU
Barrington Cuts Price Target on Cross Country Healthcare to $24 From $26, Keeps Outperform Rating	Feb. 27	MT
CROSS COUNTRY HEALTHCARE TO ATTEND THE OPPENHEIMER 34TH ANNUAL HEALTHCARE CONFERENCE	Feb. 26	AQ
Cross Country Healthcare to Attend the Oppenheimer 34th Annual Healthcare Conference	Feb. 23	BU
UBS Adjusts Cross Country Healthcare Price Target to $19 From $22, Maintains Neutral Rating	Feb. 23	MT
CROSS COUNTRY HEALTHCARE CEO FEATURED ON 2024 STAFFING INDUSTRY ANALYSTS 100 IN STAFFING LIST	Feb. 23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cross Country Healthcare, Inc.

Equities

CCRN

US2274831047

Summary

Filters